Peter E. Zage
Impact in
- Neurology top 1%
- Neuroblastoma Research and Treatments
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 49
- Neuroblastoma Research and Treatments 49
- Neurofibromatosis and Schwannoma Cases 2
-
- Cancer therapeutics and mechanisms 9
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 6
- Co-authors
- Sarah Burkhead Whittle (6 shared papers)Valeria Smith (3 shared papers)Erin Doherty (1 shared paper)Sibo Zhao (1 shared paper)Susan L. Cohn (5 shared papers)Patrick A. Zweidler‐McKay (7 shared papers)Linna Zhang (8 shared papers)Sarah E. Woodfield (7 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Pediatric Blood & Cancer (5 papers)Cancer (5 papers)Investigational New Drugs (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Peter E. Zage
63 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Neurology 823
- Cancer Research 377
- Genetics 142
- Molecular Biology 904
- Oncology 286
Countries citing papers authored by Peter E. Zage
This map shows the geographic impact of Peter E. Zage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Zage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Zage more than expected).
Fields of papers citing papers by Peter E. Zage
This network shows the impact of papers produced by Peter E. Zage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Zage. The network helps show where Peter E. Zage may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter E. Zage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 283 | |
| 2 | 2005 | 98 | |
| 3 | 2004 | 77 | |
| 4 | 2008 | 70 | |
| 5 | 2010 | 65 | |
| 6 | 2016 | 56 | |
| 7 | 2009 | 54 | |
| 8 | 2011 | 53 | |
| 9 | 2020 | 48 | |
| 10 | 2011 | 47 | |
| 11 | 2011 | 43 | |
| 12 | 2010 | 42 | |
| 13 | 2011 | 42 | |
| 14 | 2013 | 42 | |
| 15 | 2018 | 41 | |
| 16 | 2014 | 40 | |
| 17 | 2020 | 38 | |
| 18 | 2014 | 38 | |
| 19 | 2005 | 37 | |
| 20 | 2010 | 37 |
About Peter E. Zage
Peter E. Zage is a scholar working on Neurology, Molecular Biology, Cancer Research, Genetics and Oncology, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (49 papers), Cancer, Hypoxia, and Metabolism (13 papers), Cancer therapeutics and mechanisms (9 papers), Ubiquitin and proteasome pathways (8 papers), Glioma Diagnosis and Treatment (7 papers), Protein Degradation and Inhibitors (6 papers), Microtubule and mitosis dynamics (4 papers) and Neurofibromatosis and Schwannoma Cases (2 papers). The work is most often cited by research in Neurology (823 citations), Cancer Research (377 citations), Genetics (142 citations), Molecular Biology (904 citations) and Oncology (286 citations). Peter E. Zage has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Sarah Burkhead Whittle, Valeria Smith, Erin Doherty, Sibo Zhao, Susan L. Cohn, Patrick A. Zweidler‐McKay, Linna Zhang, Sarah E. Woodfield, Alexandre Chlenski and Helen R. Salwen. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer, Investigational New Drugs and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.